On Tuesday, Qiagen NV (NYSE: QGEN) was -0.28% down from the session before settling in for the closing price of $42.82. A 52-week range for QGEN has been $34.74 – $47.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 6.29%. When this article was written, the company’s average yearly earnings per share was at 0.58%. With a float of $220.34 million, this company’s outstanding shares have now reached $226.45 million.
Let’s determine the extent of company efficiency that accounts for 5967 employees.
Qiagen NV (QGEN) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Qiagen NV stocks. The insider ownership of Qiagen NV is 0.46%, while institutional ownership is 59.40%.
Qiagen NV (QGEN) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/30/2023, it has been observed that the corporation posted $0.55 earnings per share (EPS) during the time that was better than consensus figure (set at $0.55) by $0. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.66% during the next five years compared to 12.66% growth over the previous five years of trading.
Qiagen NV (NYSE: QGEN) Trading Performance Indicators
You can see what Qiagen NV (QGEN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.81. Likewise, its price to free cash flow for the trailing twelve months is 30.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.53, a number that is poised to hit 0.44 in the next quarter and is forecasted to reach 2.30 in one year’s time.
Technical Analysis of Qiagen NV (QGEN)
Looking closely at Qiagen NV (NYSE: QGEN), its last 5-days average volume was 0.81 million, which is a drop from its year-to-date volume of 1.28 million. As of the previous 9 days, the stock’s Stochastic %D was 22.09%. Additionally, its Average True Range was 0.66.
During the past 100 days, Qiagen NV’s (QGEN) raw stochastic average was set at 63.65%, which indicates a significant increase from 20.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 13.73% in the past 14 days, which was lower than the 20.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.83, while its 200-day Moving Average is $42.85. However, in the short run, Qiagen NV’s stock first resistance to watch stands at $42.91. Second resistance stands at $43.11. The third major resistance level sits at $43.53. If the price goes on to break the first support level at $42.29, it is likely to go to the next support level at $41.87. Should the price break the second support level, the third support level stands at $41.67.
Qiagen NV (NYSE: QGEN) Key Stats
There are 228,203K outstanding shares of the company, which has a market capitalization of 9.45 billion. As of now, sales total 1,965 M while income totals 341,300 K. Its latest quarter income was 509,160 K while its last quarter net income were 97,660 K.
